Eris Lifesciences Limited

NSE:ERIS.NS

1369.45 (INR) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q22016 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 1,500.2-14,006.3214,006.3-1,906.241,727.14-892.43560.22-709.59677.11-2,123.17507.94-1,487.26426.71-1,365.06368.7-2,052.6512.14-1,537.18672.11-2,481.62122.82-3,353.9675-816.14143.41-1,127.01106.08-2,665.1257.29-2,609.0424.2197.41-1,371.39
Short Term Investments 96428,012.640.023,812.48195.21,784.86332.211,419.1832.484,246.341,264.472,974.521,060.552,730.12153.994,105.21,540.463,074.36747.814,963.242,358.86,707.923,149.421,632.28672.732,254.02937.895,330.242,607.835,218.082,584.832,522.82,742.78
Cash and Short Term Investments 2,464.214,006.3214,006.321,906.241,922.34892.43892.43709.59709.592,123.171,772.411,487.261,487.261,365.06522.692,052.62,052.61,537.181,419.922,481.622,481.623,353.963,224.42816.14816.141,127.011,043.972,665.122,665.122,609.042,609.042,620.211,371.39
Net Receivables 5,67504,275.8303,549.0202,966.9502,95701,61001,669.602,280.6101,954.2301,568.8401,408.2801,760.3701,175.090761.30934.410603.99561.390
Inventory 2,562.801,890.3201,390.8901,314.3501,085.1901,179.1101,031.420944.660902.670694.750720.910826.530582.640654.480357.550558.2507.460
Other Current Assets 8,149.602,848.2602,749.2602,473.4901,354.9401,060.8501,035.650922.501,087.7602,681.50703.7406.470702.540527.320319.3073.54191.860
Total Current Assets 13,176.614,006.3223,020.731,906.249,611.51892.437,647.22709.596,154.362,123.176,273.31,487.265,223.931,365.064,670.462,052.65,997.261,537.184,796.172,481.625,314.553,353.965,817.79816.143,276.411,127.012,987.072,665.124,276.382,609.043,844.773,880.921,371.39
Non-Current Assets:
Property, Plant & Equipment, Net 5,204.405,236.5304,224.6303,773.7902,994.1501,918.5701,404.30778.780778.680872.430951.040560.710590.030526.120550.660553.86610.430
Goodwill 8,942.608,612.1303,318.4903,318.4903,378.620934.740934.740934.740934.740934.740935.870935.870934.7401,869.480371.590792.6100
Intangible Assets 38,875.2029,623.25018,236.07018,805.96012,874.3706,595.9806,691.7406,840.7606,907.7906,984.6906,084.3206,136.0806,193.9806,250.0701,462.350363.34377.370
Goodwill and Intangible Assets 47,817.8038,235.38021,554.56022,124.45016,252.9907,530.7207,626.4807,775.507,842.5307,919.4307,020.1907,071.9507,128.7208,119.5501,833.9401,155.95377.370
Long Term Investments 531.50259.140-52.34068.77042.2304,208.4403,851.7702,282.460-1,409.250-715.770-1,881.50-2,740.302,207.3901,797.380-1,042.270-2,483.86100.970
Tax Assets 2,890.303,069.4102,951.0302,739.4502,694.8602,431.3402,271.7202,006.3201,952.1301,709.1101,591.8801,447.9401,253.9201,005.670789.76095.1500
Other Non-Current Assets 598.2-14,006.32667.18-1,906.24462.49-892.43319.6-709.59552.78-2,123.17359.02-1,487.26139.24-1,365.06834.28-2,052.61,685.58-1,537.18941.68-2,481.622,508.73-3,353.963,378.53-816.14752.11-1,127.01165.06-2,665.122,676.05-2,609.043,244.1521.2-1,371.39
Total Non-Current Assets 57,042.2-14,006.3247,467.64-1,906.2429,140.37-892.4329,026.06-709.5922,537.01-2,123.1716,448.09-1,487.2615,293.51-1,365.0613,677.34-2,052.610,849.67-1,537.1810,726.88-2,481.6210,190.34-3,353.969,718.83-816.1411,932.17-1,127.0111,613.78-2,665.124,808.14-2,609.042,565.21,609.97-1,371.39
Total Assets 70,218.8070,488.37038,751.88036,673.28028,691.37022,721.39020,517.44018,347.8016,846.93015,523.05015,504.89015,536.62015,208.58014,600.8509,084.5206,409.975,490.890
Liabilities & Equity:
Current Liabilities:
Account Payables 2,817.402,683.4801,505.2501,247.6901,165.701,177.7401,167.8201,026.160994.2901,000.510729.480841.250893.750907.740607.120385.17608.350
Short Term Debt 7,287.2020,897.4301,970.3101,932.901,391.27040.13043.69023.3037.08059.99086.1601,761.301,023.2601,026.0400072.6544.330
Tax Payables 3380395.90137.960390141.24069.970192.83077.510126.43069.98023.28018.11018.82025.57083.520000
Deferred Revenue 3380395.901,274.4401,034.5208060626.220561.4077.510493.720424.320397.510271.410-1,023.260225.57000241.7600
Other Current Liabilities -1,255.20-1,735.420-1,421.830-1,069.470-1,071.430-1,095.340-1,147.020-561.330-907.660-908.410-577.760-677.950446.130-838.060-303.360-326.56-295.550
Total Current Liabilities 12,342.8025,320.7704,971.3804,432.3303,598.4801,996.4601,986.5401,669.3101,738.1501,646.901,388.1503,055.3702,252.4502,254.60994.40758.19965.480
Non-Current Liabilities:
Long Term Debt 19,665.206,545.0706,324.7306,834.2101,227.550803.940399.73044.47051.13061.44083.1102.9301,747.8402,741.9504.2404.9400
Deferred Revenue Non-Current 313.10370.190536.1087.390550.29056.880372.61061.110350.98085.450252.62066.630228.250209.720190.43010.7800
Deferred Tax Liabilities Non-Current 5,274.305,428.1802,533.0402,576.3802,618.160460.940478.150495.380500.740506.150511.550516.950520.580522.70343.040211.5300
Other Non-Current Liabilities 851.9-32,220.31603.850110.90536.20124.960321.14024.650313.3026.410259.77030.640206.47012.36012.16011.48025.2900
Total Non-Current Liabilities 26,104.5-32,220.3112,947.2909,504.77010,034.1804,520.9601,642.901,275.140914.260929.260912.810877.920792.9802,509.0303,486.530549.190252.5400
Total Liabilities 38,447.3-32,220.3138,268.06014,476.15014,466.5108,119.4403,639.3603,261.6802,583.5702,667.4102,559.7102,266.0703,848.3504,761.4805,741.1301,543.5901,010.73965.480
Equity:
Preferred Stock 00000021,930.1200018,978.590000000000000000000000
Common Stock 1360136.030136.020135.990135.990135.930135.910135.780135.780135.780137.520137.50137.520137.50137.50137.5137.50
Retained Earnings 0025,492.5700021,559.300018,736.5300015,503.1300012,797.2800011,335.22010,057.9908,468.570005,254.744,155.240
Accumulated Other Comprehensive Income/Loss 025,861.1951,450.3224,115.6823,979.6621,959.8829.7620,269.3720,133.3819,083.11104.5217,255.7417,119.8315,764.21135.7814,179.514,043.7212,963.34-711.3313,238.8213,101.311,505.18-543.9910,195.5108,613.0707,306.797,169.295,399.24-619.9602,992.44
Other Total Stockholders Equity 27,578.76,359.12-51,217.73160.050246.89-21,695.29302.560-1.08-18,872.460.0200.02-10.480.0200741.6100183.11576.43251.590246.657234.1400626.96-4,292.7432.01
Total Shareholders Equity 27,714.732,220.3125,861.1924,275.7324,115.6822,206.7721,959.8820,571.9320,269.3719,082.0319,083.1117,255.7617,255.7415,764.2315,764.2114,179.5214,179.512,963.3412,963.3413,238.8213,238.8211,688.2911,505.1610,447.110,195.518,859.728,613.077,540.937,306.795,399.245,399.244,292.743,024.45
Total Equity 31,771.532,220.3132,220.3124,275.7324,275.7322,206.7722,206.7720,571.9320,571.9319,082.0319,082.0317,255.7617,255.7615,764.2315,764.2314,179.5214,179.5212,963.3412,963.3413,238.8213,238.8211,688.2911,688.2710,447.110,447.18,859.728,859.727,540.937,540.935,399.245,637.174,292.743,024.45
Total Liabilities & Shareholders Equity 70,218.832,220.3170,488.3724,275.7338,751.8822,206.7736,673.2820,571.9328,691.3719,082.0322,721.3917,255.7620,517.4415,764.2318,347.814,179.5216,846.9312,963.3415,523.0513,238.8215,504.8911,688.2915,536.6210,447.115,208.588,859.7214,600.857,540.939,084.525,399.246,409.975,258.223,024.45